Status:
COMPLETED
Effects Of Prednisolone On Rheumatoid Arthritis Patients
Lead Sponsor:
GlaxoSmithKline
Conditions:
Arthritis, Rheumatoid
Eligibility:
All Genders
25-75 years
Brief Summary
This study will assess the Pharmacokinetic (PK) and Pharmacodynamic (PD) effects of Prednisolone on Rheumatoid Arthritis (RA) patients.
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Meet the ACR criteria for diagnosis of rheumatoid arthritis.
- Required treatment with Prednisolone.
- Currently on a non-steroidal anti-inflammatory agent (NSAID).
- Willing to stay on current dose of NSAID for two weeks during study.
- Exclusion criteria:
- Major health issues such as osteoporosis, diabetes, heart failure, heart attack, kidney failure, or acute infection.
Exclusion
Key Trial Info
Start Date :
February 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2006
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT00330889
Start Date
February 1 2004
End Date
December 1 2006
Last Update
October 22 2012
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Birmingham, Alabama, United States, 35249
2
GSK Investigational Site
Los Angeles, California, United States, 90095
3
GSK Investigational Site
Omaha, Nebraska, United States, 68198
4
GSK Investigational Site
Philadelphia, Pennsylvania, United States, 19104